HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYN


Around the Helix: Cell and Gene Therapy Company Updates – January 18, 2023

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CAR-T for NMOSD Demonstrates Manageable Safety in Phase 1 Trial

It was previously announced that CT103A received FDA clearance of its investigational new drug application for the treatment of relapsed/refractory (r/r) multiple myeloma.

Neovascular AMD Gene Therapy Cleared for Trials

A phase 1 clinical trial of EXG102-031 is expected to initiate in the first quarter of 2023.